Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins
Meng-Hsiung Hsieh, … , John T. Powers, Hao Zhu
Meng-Hsiung Hsieh, … , John T. Powers, Hao Zhu
Published June 14, 2024
Citation Information: J Clin Invest. 2024;134(15):e165734. https://doi.org/10.1172/JCI165734.
View: Text | PDF
Research Article Hepatology

Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins

  • Text
  • PDF
Abstract

It is unknown which posttranscriptional regulatory mechanisms are required for oncogenic competence. Here, we show that the LIN28 family of RNA-binding proteins (RBPs), which facilitate posttranscriptional RNA metabolism within ribonucleoprotein networks, is essential for the initiation of diverse oncotypes of hepatocellular carcinoma (HCC). In HCC models driven by NRASG12V/Tp53, CTNNB1/YAP/Tp53, or AKT/Tp53, mice without Lin28a and Lin28b were markedly impaired in cancer initiation. We biochemically defined an oncofetal regulon of 15 factors connected to LIN28 through direct mRNA and protein interactions. Interestingly, all were RBPs and only 1 of 15 was a Let-7 target. Polysome profiling and reporter assays showed that LIN28B directly increased the translation of 8 of these 15 RBPs. As expected, overexpression of LIN28B and IGFBP1-3 was able to genetically rescue cancer initiation. Using this platform to probe components downstream of LIN28, we found that 8 target RBPs were able to restore NRASG12V/Tp53 cancer formation in Lin28a/Lin28b-deficient mice. Furthermore, these LIN28B targets promote cancer initiation through an increase in protein synthesis. LIN28B, central to an RNP regulon that increases translation of RBPs, is important for tumor initiation in the liver.

Authors

Meng-Hsiung Hsieh, Yonglong Wei, Lin Li, Liem H. Nguyen, Yu-Hsuan Lin, Jung M. Yong, Xuxu Sun, Xun Wang, Xin Luo, Sarah K. Knutson, Christina Bracken, George Q. Daley, John T. Powers, Hao Zhu

×

Figure 6

A subset of LIN28’s RBP targets can rescue tumorigenesis in Lin28a/Lin28b/Tp53-TKO mice in part through increases in protein synthesis.

Options: View larger image (or click on image) Download as PowerPoint
A subset of LIN28’s RBP targets can rescue tumorigenesis in Lin28a/Lin28...
(A) Representative gross images of Lin28a/Lin28b/Tp53-TKO mice receiving NRASG12V in combination with pT3-RBPs (n > 3), pT3-eGFP (n = 5), or pT3-Luciferase (n = 5) for 7 weeks. Scale bars: 1 cm. All the images can also be found in Supplemental Figures 5B and 9. (B) Surface tumor number for A. One-way ANOVA was performed. (C) Liver-to-body weight ratios for A. One-way ANOVA was performed. (D) WB analysis quantified OP-puro labeling protein in Huh7 cells with Lin28b knockdown plus target overexpression. Number below the box shows relative intensity. (E) Representative gross images of Tp53-KO (Albumin-Cre; Tp53fl/fl; n = 5) and Lin28a/Lin28b/Tp53-TKO (Albumin-Cre; Tp53fl/fl; Lin28afl/fl; Lin28bfl/fl) mice that received NRASG12V by HDT for 7 weeks. TKO mice were subjected to BAZ2A inhibitors (n = 6) or DMSO (n = 5) once per week starting 3 days after HDT. Scale bars: 1 cm. One-way ANOVA was performed. (F) Schematic shows the importance of LIN28 proteins for tumor initiation. The image was designed and drawn using BioRender. **P < 0.01; ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts